Get the Stockscreener App
3.24
0.62%
0.02
After Hours:
3.25
0.010
+0.31%
Aclarion Inc stock is traded at $3.24, with a volume of 25,810.
It is up +0.62% in the last 24 hours and up +25.10% over the past month.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
See More
Previous Close:
$3.22
Open:
$3.22
24h Volume:
25,810
Relative Volume:
0.03
Market Cap:
$3.42M
Revenue:
$67,500
Net Income/Loss:
$-7.33M
P/E Ratio:
-0.00202
EPS:
-1602.9371
Net Cash Flow:
$-6.66M
1W Performance:
-1.22%
1M Performance:
+25.10%
6M Performance:
-57.52%
1Y Performance:
-86.27%
1-Day Range:
$3.20
$3.3105
1-Week Range:
$3.19
$3.50
52-Week Range:
$2.3401
$24.91
Aclarion Inc Stock (ACON) Company Profile
Name
Aclarion Inc
Sector
Industry
Phone
833 275 2266
Address
8181 ARISTA PLACE, BROOMFIELD
Compare ACON vs VEEV, TEM, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
3.24 | 3.40M | 67,500 | -7.33M | -6.66M | -1,602.94 |
|
VEEV
Veeva Systems Inc
|
186.70 | 30.46B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
50.84 | 9.10B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
42.10 | 7.50B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
79.40 | 6.72B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
24.75 | 4.72B | 1.10B | 112.09M | 283.19M | 0.6096 |
Aclarion Inc Stock (ACON) Latest News
Is Aclarion Inc Equity Warrant still a buy after recent gainsQuarterly Profit Report & Safe Entry Trade Reports - baoquankhu1.vn
Aclarion, Inc. to Engage with Investors at the 38th Annual ROTH Conference Regarding Nociscan Advancements - Quiver Quantitative
Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet - Bitget
Back pain scan firm Aclarion meets investors at ROTH with no debt - Stock Titan
Investment Review: Whats the outlook for Aclarion Inc Equity Warrants sectorWeekly Market Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Aug Shorts: Is Aclarion Inc Equity Warrant benefiting from interest rate changes2026 Technical Overview & Consistent Profit Alerts - baoquankhu1.vn
Aclarion CEO to Present AI-Powered Back Pain Diagnostic Technology at Leading MedTech Conference - citybuzz -
Aclarion CEO Brent Ness to Attend LSI USA 2026 - Bitget
Aclarion, Inc. CEO Brent Ness to Attend LSI USA 2026 to Discuss NOCISCAN and Industry Partnerships - Quiver Quantitative
Quarterly Risk: Is Aclarion Inc Equity Warrant stock undervalued right nowQuarterly Profit Review & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Decliners Report: Is Aclarion Inc Equity Warrant attractive for institutional investorsTrade Volume Report & Growth-Oriented Investment Plans - baoquankhu1.vn
What is Aclarion Inc Equity Warrants 5 year growth outlookJuly 2025 Spike Watch & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Will Aclarion Inc. stock benefit from upcoming earnings reports2026 Chart Watch & Proven Capital Preservation Methods - Naître et grandir
Aug EndMonth: How Aclarion Inc. Equity Warrant stock reacts to job market dataTrade Analysis Report & Accurate Buy Signal Notifications - Naître et grandir
Dividend Watch: Will Aclarion Inc Equity Warrant outperform during market rallies2025 Analyst Calls & Breakout Confirmation Alerts - baoquankhu1.vn
Analyst Calls: Will Aclarion Inc Equity Warrant outperform during market ralliesIndex Update & Consistent Return Strategy Ideas - baoquankhu1.vn
Bank Watch: Does Five Below Inc stock have upside surprise potentialMarket Activity Recap & Safe Entry Momentum Tips - baoquankhu1.vn
Retail Trends: Whats next for CalciMedica Inc stock2025 Sector Review & Technical Entry and Exit Tips - baoquankhu1.vn
ACON PE Ratio & Valuation, Is ACON Overvalued - Intellectia AI
Activity Recap: Is Tidewater Inc forming a breakout patternWeekly Market Outlook & Weekly Top Stock Performers List - baoquankhu1.vn
ACON Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Volatility Watch: Is Aclarion Inc still a buy after recent gainsTrade Risk Summary & High Return Stock Watch Alerts - baoquankhu1.vn
Trading Recap: Whats the outlook for Aclarion Inc Equity Warrants sectorJuly 2025 Summary & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Investor Mood: Is Aclarion Inc Equity Warrant still a buy after recent gains - baoquankhu1.vn
Market Wrap: Is Aclarion Inc Equity Warrant stock undervalued right now2025 Big Picture & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Can Aclarion Inc. Equity Warrant stock continue upward trend2025 Key Lessons & Safe Entry Momentum Stock Tips - mfd.ru
US Market Wrap: Should I hold or sell Aclarion Inc. Equity Warrant now2025 Short Interest & Stepwise Entry and Exit Trade Signals - mfd.ru
Is Aclarion Inc. stock positioned for long term growthWeekly Earnings Recap & Consistent Income Trade Ideas - mfd.ru
ACON Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
ACON Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Can Aclarion Inc. weather a recessionNew Guidance & Verified Stock Trade Ideas - mfd.ru
What are Aclarion Inc.’s earnings expectationsWeekly Stock Report & Reliable Price Action Trade Plans - mfd.ru
Earnings Beat: Is TriSalus Life Sciences Inc Equity Warrant a strong growth stock2025 Growth vs Value & Short-Term Trading Alerts - baoquankhu1.vn
What’s the outlook for Aclarion Inc. Equity Warrant’s sectorWeekly Investment Report & Low Drawdown Trading Strategies - mfd.ru
NeuroOne Medical Technologies (NASDAQ:NMTC) versus Aclarion (NASDAQ:ACON) Head to Head Contrast - Defense World
How does Aclarion Inc. Equity Warrant correlate with NasdaqWeekly Investment Summary & Daily Chart Pattern Signals - mfd.ru
How does Aclarion Inc. compare to its peersInsider Selling & Precise Trade Entry Recommendations - mfd.ru
Market Leaders: Whats the outlook for Aclarion Inc Equity Warrants sectorWeekly Profit Report & Short-Term High Return Ideas - baoquankhu1.vn
Analyst Upgrade: Does SPOT have declining or rising EPSOil Prices & Community Trade Idea Sharing - baoquankhu1.vn
Aclarion secures $10.4M for back-pain diagnostic technology - BizWest
Aclarion Publishes 2026 Shareholder Letter from the Chairman - The Globe and Mail
Aclarion, Inc. Announces Strong Financial Position and Path to CLARITY Trial Milestones Ahead of 2026 - Quiver Quantitative
No new funding planned as Aclarion awaits back pain trial data in 2026 - Stock Titan
EXCLUSIVE: Aclarion CEO Looks To Bigger AI MedTech’s Playbook To Reverse Fortunes - Asianet Newsable
Aclarion CEO Outlines 2026 Execution Plan Focused on Reimbursement and Adoption - intellectia.ai
Aclarion CEO Bets On Bigger AI MedTech’s Playbook To Revive Sagging Stock - Stocktwits
Aclarion partners with Source Healthcare to expand Nociscan availability By Investing.com - Investing.com Nigeria
Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation - Ortho Spine News
Aclarion Expands Nociscan Availability in Greater Los Angeles - Intellectia AI
Aclarion partners with Source Healthcare to expand Nociscan availability - Investing.com
Aclarion Expands Nociscan Availability in Greater Los Angeles Area Through Partnership with Source Healthcare - Quiver Quantitative
Aclarion Inc Stock (ACON) Financials Data
Revenue
Net Income
Cash Flow
EPS
8.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):